Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.

FDA highlights risks of evaluating blood pressure with unauthorized medical devices
The agency emphasized that many over-the-counter technologies marketed for this purpose have not been properly evaluated.
Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately
The FDA has categorized this as a Class I recall. If patients update their phone or watch apps as needed, they can continue to use these devices like normal.
Plant-based diets linked to lower risks of death, heart disease, stroke and diabetes
Diets that prioritize plant-based foods are associated with several health benefits, according to a new study of more than 3.4 million adults. Such diets also show potential to reduce greenhouse gas emissions.
Health systems use AI to target patients who may have elevated Lp(a) levels
"We can start helping people right now, and it would be meaningful if we can raise more awareness to reduce the burden of CVD," explained Katherine Wilemon, founder and CEO of the Family Heart Foundation.
Oral GLP-1 drug linked to weight loss in patients with and without diabetes—is FDA approval next?
Eli Lilly and Company is back with even more positive data on orforglipron, its oral GLP-1 receptor agonist. The company says it is "moving with urgency" toward gaining key regulatory approvals and getting the drug in the hands of patients.

Advanced age, hypertension among predictors of AFib in ESUS patients

The analysis included more than 5,000 patients who received care from December 2014 to January 2018 in one of 42 countries.

FDA approves expansion of clinical support system to include patients with type 2 diabetes

The platform is now approved as a treatment option for patients with both type 1 and type 2 diabetes.

Cardiologists can make a difference by promoting flu shots, debunking vaccine misinformation

An international team of specialists from the Netherlands and New York made their case in a new editorial.

FDA announces recall of 2 hypertension medications

The affected batches were distributed from October 2018 to December 2020.

FDA clears Rethymic for rare pediatric immune disorder

The application was granted a rare pediatric disease voucher by the FDA.

Many PAD patients are missing out on vital risk assessments

The findings, based on Medicare data, were presented at VIVA21 in Las Vegas.

How health systems could do more to help hypertension patients

Text-based reminders, simplified prescriptions and real-time counseling are just some of the suggestions mentioned in a new scientific statement from the American Heart Association.

Early onset hypertension associated with brain structure changes, dementia

An active screening program designed to identify people with early hypertension and provide aggressive high blood pressure treatment may help reduce the risk of developing dementia in the future.

Heart Health

FDA highlights risks of evaluating blood pressure with unauthorized medical devices

Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately

Plant-based diets linked to lower risks of death, heart disease, stroke and diabetes

Health systems use AI to target patients who may have elevated Lp(a) levels

Oral GLP-1 drug linked to weight loss in patients with and without diabetes—is FDA approval next?